09:52 AM EST - Nordion Inc. : extended its contract with its primary Medical Isotopes customer, Lantheus Medical Imaging, Inc. (LMI) for the supply of Molybdenum-99 (Mo-99). Under the terms of the amended agreement, the contract has been extended for an additional two years through 2015. Nordion expects to supply Mo-99 on a weekly basis to Lantheus Medical Imaging. The multi-year contract reflects specific pricing for each year of the contract. Lantheus is Nordion’s single largest customer, purchasing the majority of Nordion’s Mo-99. Nordion Inc.
shares T.NDN are trading up $0.12 at $6.38.
